Condition category
Circulatory System
Date applied
14/04/2006
Date assigned
13/06/2006
Last edited
13/06/2006
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

http://www.uni-essen.de/neurologie/stroke/

Contact information

Type

Scientific

Primary contact

Dr Christian Weimar

ORCID ID

Contact details

Hufelandstr. 55
Essen
45122
Germany
+49 (0)201 723 2495
stroke.med@uni-essen.de

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

DI 327/9-1

Study information

Scientific title

Acronym

Study hypothesis

To determine the rate of recurrence in patients with cerebrovascular events of defined etiology

Ethics approval

Ethics Committee of the University of Essen reviewed the protocol of this trial and confirmed that ethical approval was not required.

Study design

Prospective observational cohort study

Primary study design

Interventional

Secondary study design

Cohort study

Trial setting

Not specified

Trial type

Diagnostic

Patient information sheet

Condition

Cerebral stroke and TIA

Intervention

Patients are followed-up via telephone interview to determine the long-term rate of recurrence in patients with predefined stroke etiologies

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Recurrent stroke

Secondary outcome measures

Mortality of any cause

Overall trial start date

01/09/2002

Overall trial end date

31/12/2009

Reason abandoned

Eligibility

Participant inclusion criteria

Patients with acute cerebrovascular events of defined etiology including:
1. Cardiac right-to-left shunt
2. Transient ischemic attack (TIA) with symptoms lasting <1 hour
3. Intracerebral bleeding
4. Intracranial stenosis
5. Dissection of brain supplying arteries
6. Coagulation disorder
7. Previous history of migraine
8. Basilar artery occlusion
9. Vasculitis
10. Arteriovenous malformation
11. Moyamoya syndrome

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

3000

Participant exclusion criteria

Inability or refusal to provide consent for study participation

Recruitment start date

01/09/2002

Recruitment end date

31/12/2009

Locations

Countries of recruitment

Germany

Trial participating centre

Hufelandstr. 55
Essen
45122
Germany

Sponsor information

Organisation

German Research Foundation (Deutsche Forschungsgemeinsschaft) (DFG)

Sponsor details

Kennedeyallee 40
Bonn
53175
Germany
theodora.hogenkamp@dfg.de

Sponsor type

Research organisation

Website

http://www.dfg.de

Funders

Funder type

Research organisation

Funder name

German Research Foundation (Deutsche Forschungsgemeinsschaft) (DFG) DI 327/9-1

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes